The Noggin null mouse phenotype is strain dependent and haploinsufficieny leads to skeletal defects

Developmental Dynamics

Volumn 235, Issue 6, 2006, Pages 1599-1607

  Tylzanowski, Przemko ^a   Mebis, Liese ^a   Luyte, Frank P ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

BMPs; Haploinsufficiency; Limb; Myogenesis; Noggin

Indexed keywords

BONE MORPHOGENETIC PROTEIN; NOGGIN; TRANSFORMING GROWTH FACTOR BETA;

129X1 SVJ MOUSE; ANIMAL TISSUE; ARTHRODESIS; ARTICLE; BONE MINERALIZATION; C57BL 6 MOUSE; CARTILAGE; CARTILAGE CELL; CARTILAGE HYPERPLASIA; CD1 MOUSE; DBA 1 MOUSE; EMBRYO; GENE; GENE INACTIVATION; GENE LOSS; GENETIC CROSS; HAPLOINSUFFICIENCY; HAPLOTYPE; HEEL; HYPERPLASIA; INBRED STRAIN; LETHALITY; LIMB DEVELOPMENT; MOUSE; MOUSE STRAIN; MUSCLE DEVELOPMENT; NOGGIN GENE; NONHUMAN; NULL ALLELE; OUTBRED STRAIN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SKELETON MALFORMATION; TISSUE REACTION; WRIST;

ANIMALS; BONE AND BONES; CARRIER PROTEINS; EXTREMITIES; LIMB DEFORMITIES, CONGENITAL; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUSCLE, SKELETAL; SKIN; SKIN ABNORMALITIES;

VERTEBRATA;

EID: 33646872488     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.20782     Document Type: Article

References (42)

1. Andres V, Walsh K. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132:657-666.
2. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ. 1996. Genetic variability in adult bone density among inbred strains of mice. Bone 18:397-403.
3. Beamer WG, Donahue LR, Rosen CJ. 2002. Genetics and bone. Using the mouse to understand man. J Musculoskel Neuronal Interact 2:225-231.
4. Beier DR, Herron BJ. 2004. Genetic mapping and ENU mutagenesis. Genetica 122: 65-69.
5. Botchkarev VA, Botchkareva NV, Roth W, Nakamura M, Chen LH, Herzog W, Lindner G, McMahon JA, Peters C, Lauster R, McMahon AP, Paus R. 1999. Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol 1:158-164.
6. Brown DJ, Kim TB, Petty EM, Downs CA, Martin DM, Strouse PJ, Moroi SE, Milunsky JM, Lesperance MM. 2002. Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet 71:618-624.
7. Brunet LJ, McMahon JA, McMahon AP, Harland RM. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280: 1455-1457.
8. Chang C, Hemmati-Brivanlou A. 1999. Xenopus GDF6, a new antagonist of noggin and a partner of BMPs. Development 126: 3347-3357.
9. Chow LH, Boughner DR, Dunmore-Buyze J, Finlay H, Pickering JG. 2001. Enhanced detection of cardiac myocyte damage by polarized light microscopy. Use in a model of coxsackievirus B3-induced myocarditis. Cardiovasc Pathol 10: 83-86.
10. Daluiski A, Engstrand T, Bahamonde ME, Gamer LW, Agius E, Stevenson SL, Cox K, Rosen V, Lyons KM. 2001. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 27:84-88.
11. Debeer P, Huysmans C, Van de Ven WJ, Fryns JP, Devriendt K. 2005. Carpal and tarsal synostoses and transverse reduction defects of the toes in two brothers heterozygous for a double de novo NOGGIN mutation. Am J Med Genet A 134: 318-320.
12. De Robertis EM, Kuroda H. 2004. Dorsalventral patterning and neural induction in Xenopus embryos. Annu Rev Cell Dev Biol 20:285-308.
13. Dixon ME, Armstrong P, Stevens DB, Bamshad M. 2001. Identical mutations in NOG can cause either tarsal/carpal coalition syndrome or proximal symphalangism. Genet Med 3:349-353.
14. Errijgers V, Kooy RF. 2004. Genetic modifiers in mice: the example of the fragile X mouse model. Cytogenet Genome Res 105: 448-454.
15. Feng XH, Derynck R. 2005. Specificity and versatility in TGF-signaling through Smads. Annu Rev Cell Dev Biol 21:659-693.
16. Fleming RE, Holden CC, Tomatsu S, Waheed A, Brunt EM, Britton RS, Bacon BR, Roopenian DC, Sly WS. 2001. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci USA 98:2707-2711.
17. Francis-West PH, Antoni L, Anakwe K. 2003. Regulation of myogenic differentiation in the developing limb bud. J Anat 202:69-81.
18. Gamer LW, Nove J, Levin M, Rosen V. 2005. BMP-3 is a novel inhibitor of both activin and BMP-4 signaling in Xenopus embryos. Dev Biol 285:156-168.
19. Gong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, Hudgins L, Cremers CW, Cremers FP, Brunner HG, Reinker K, Rimoin DL, Cohn DH, Goodman FR, Reardon W, Patton M, Francomano CA, Warman ML. 1999. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 21:302-304.
20. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC, Choe S. 2002. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420: 636-642.
21. Hogan BL, Beddington RS, Constantini F, Lacy E. 1994. Manipulating the mouse embryo. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
22. Hogan BL. 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594.
23. Ju W, Hoffmann A, Verschueren K, Tylzanowski P, Kaps C, Gross G, Huylebroeck D. 2000. The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2. J Bone Miner Res 15:1889-1899.
24. Kallapur S, Ormsby I, Doetschman T. 1999. Strain dependency of TGFbeta1 function during embryogenesis. Mol Reprod Dev 52:341-349.
25. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128:following 713]. J Cell Biol 127:1755-1766.
26. Li G, Peng H, Corsi K, Usas A, Olshanski A, Huard J. 2005. Differential effect of BMP4 on NIH/3T3 and C2C12 cells: implications for endochondral bone formation. J Bone Miner Res 20:1611-1623.
27. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J, Huard J. 2004. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 164:1007-1019.
28. McMahon JA, Takada S, Zimmerman LB, Fan CM, Harland RM, McMahon AP. 1998. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev 12:1438-1452.
29. Merino R, Macias D, Ganan Y, Economides AN, Wang X, Wu Q, Stahl N, Sampath KT, Varona P, Hurle JM. 1999. Expression and function of Gdf-5 during digit skeletogenesis in the embryonic chick leg bud. Dev Biol 206:33-45.
30. Niehrs C. 2005. Axis formation: redundancy rules. Curr Biol 15:R391-R393.
31. Nohe A, Keating E, Knaus P, Petersen NO. 2004. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16:291-299.
32. Sampath TK, Reddi AH. 1981. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci USA 78:7599-7603.
33. Sanford LP, Kallapur S, Ormsby I, DoetschmanT. 2001. Influence of genetic background on knockout mouse phenotypes. Methods Mol Biol 158:217-225.
34. Settle SH Jr, Rountree RB, Sinha A, Thacker A, Higgins K, Kingsley DM. 2003. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol 254:116-130.
35. Smith WC, Knecht AK, Wu M, Harland RM. 1993. Secreted noggin protein mimics the Spemann organizer in dorsalizing Xenopus mesoderm. Nature 361:547-549.
36. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ. 1994. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 368:639-643.
37. Tylzanowski P, Verschueren K, Huylebroeck D, Luyten FP. 2001. Smad-interacting protein 1 is a repressor of liver/bone/kidney alkaline phosphatase transcription in bone morphogenetic protein-induced osteogenic differentiation of C2C12 cells. J Biol Chem 276:40001-40007.
38. Tylzanowski P, De Valck D, Maes V, Peeters J, Luyten FP. 2003. Zfhx1a and Zfhx1b mRNAs have non-overlapping expression domains during chick and mouse midgestation limb development. Gene Express Patterns 3:39-42.
39. Urist MR. 1965. Bone: formation by auto-induction. Science 150:893-899.
40. Wijgerde M, Karp S, McMahon J, McMahon AP. 2005. Noggin antagonism of BMP4 signaling controls development of the axial skeleton in the mouse. Dev Biol 286:149-157.
41. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534.
42. Zimmerman LB, Jesus-Escobar JM, Harland RM. 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606.